Alvotech (ALVO)
5.535
-0.24
(-4.24%)
USD |
NASDAQ |
Oct 12, 13:13
Alvotech Market Cap : 1.975B for Oct. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 2.062B |
| October 08, 2026 | 2.023B |
| October 07, 2026 | 2.087B |
| October 06, 2026 | 2.191B |
| October 05, 2026 | 2.180B |
| October 02, 2026 | 1.945B |
| October 01, 2026 | 2.005B |
| September 30, 2026 | 2.070B |
| September 29, 2026 | 2.112B |
| September 28, 2026 | 2.194B |
| September 25, 2026 | 2.052B |
| September 24, 2026 | 2.098B |
| September 23, 2026 | 2.073B |
| September 22, 2026 | 2.084B |
| September 21, 2026 | 2.098B |
| September 18, 2026 | 2.095B |
| September 17, 2026 | 1.905B |
| September 16, 2026 | 1.820B |
| September 15, 2026 | 1.791B |
| September 14, 2026 | 1.802B |
| September 11, 2026 | 1.888B |
| September 10, 2026 | 1.870B |
| September 09, 2026 | 1.859B |
| September 08, 2026 | 1.852B |
| September 04, 2026 | 1.898B |
| Date | Value |
|---|---|
| September 03, 2026 | 1.920B |
| September 02, 2026 | 1.905B |
| September 01, 2026 | 1.870B |
| August 31, 2026 | 1.852B |
| August 28, 2026 | 1.766B |
| August 27, 2026 | 1.741B |
| August 26, 2026 | 1.752B |
| August 25, 2026 | 1.802B |
| August 24, 2026 | 1.873B |
| August 21, 2026 | 1.581B |
| August 20, 2026 | 1.524B |
| August 19, 2026 | 1.424B |
| August 18, 2026 | 1.409B |
| August 17, 2026 | 1.384B |
| August 14, 2026 | 1.339B |
| August 13, 2026 | 1.351B |
| August 12, 2026 | 1.324B |
| August 11, 2026 | 1.255B |
| August 10, 2026 | 1.245B |
| August 07, 2026 | 1.258B |
| August 06, 2026 | 1.255B |
| August 05, 2026 | 1.242B |
| August 04, 2026 | 1.268B |
| August 03, 2026 | 1.252B |
| July 31, 2026 | 1.361B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 317.91M |
| Amgen, Inc. | 224.79B |
| Regeneron Pharmaceuticals, Inc. | 79.23B |
| Anika Therapeutics, Inc. | 266.59M |
| BioCryst Pharmaceuticals, Inc. | 2.124B |
Market Cap Related Metrics
| PS Ratio | 3.640 |
| Price | 5.535 |
| Earnings Yield | -10.07% |
| Operating PE Ratio | 39.89 |